Histocytic Sarcoma in Dogs

If your dog has pale gums with weakness or collapse...

The hemophagocytic form of this disease destroys red blood cells and can cause severe anemia rapidly. Pale or white gums, marked weakness, collapse, rapid breathing, or a swollen abdomen warrant immediate veterinary attention.

Anemia this severe is treatable in the short term with transfusion, which can restore comfort while decisions are made.

First: Three Conditions That Are Not This

Several conditions share the word histiocytic, and most people arriving here searching that term do not have this disease. Please check this section before reading further.

Cutaneous histiocytoma is benign and very common. It appears as a small, round, red, hairless button-like lump, usually on the head, ears, or limbs of a young dog, most are under three years old. It typically grows quickly over a few weeks, then regresses and disappears on its own over one to three months without any treatment. If your young dog has a button-shaped lump and your veterinarian has diagnosed a histiocytoma, that is good news and nothing on the rest of this page applies.

Reactive histiocytosis is not cancer. Cutaneous and systemic histiocytosis are immune-mediated conditions causing skin nodules and sometimes eye or nasal involvement. They wax and wane, and they are treated with immune-suppressing medication rather than chemotherapy. They can look similar on imaging and even on initial sampling, which is one reason confirmatory testing matters.

Histiocytic sarcoma is the malignant one, and it is what the rest of this page covers.

If you are unsure which your dog has, ask your veterinarian to state it plainly. The difference is enormous.

What Histocytic Sarcoma in Dogs Is

Histiocytes are immune cells found throughout the body, in skin, lymph nodes, spleen, lungs, bone marrow, and the tissue around joints. They include dendritic cells, which present threats to the immune system, and macrophages, which engulf debris and damaged cells.

Histiocytic sarcoma is a malignant tumor of these cells. Because histiocytes are distributed everywhere, the disease can begin almost anywhere and spreads readily.

It is uncommon in the general dog population but strikingly common in a few breeds, which points to a strong genetic component.

The forms

Localized histiocytic sarcoma presents as a single mass with no evidence of spread at diagnosis. Common sites include the tissue around joints, the skin and underlying tissue, the spleen, the lungs, and lymph nodes.

Periarticular histiocytic sarcoma, the form arising around a joint, most often the knee or elbow, is the most treatable presentation and is discussed in detail below.

Disseminated histiocytic sarcoma, previously called malignant histiocytosis, involves multiple organs at diagnosis. The spleen, liver, lungs, lymph nodes, and bone marrow are commonly affected. Whether this represents rapid spread from an undetected primary site or simultaneous multi-site disease is not always clear, and practically it makes little difference.

Hemophagocytic histiocytic sarcoma arises from macrophages, usually in the spleen or bone marrow. Rather than forming a discrete mass, it spreads diffusely through those organs, and the cancerous cells destroy red blood cells and platelets.

This form has a recognizable signature on bloodwork: anemia, low platelets, and low albumin together. It carries the poorest outlook of the three, commonly measured in weeks, and it responds less well to chemotherapy than the other forms.

Which Dogs Are Affected

Bernese Mountain Dogs carry a risk unlike almost any other breed–cancer pairing in veterinary medicine. Histiocytic sarcoma accounts for a substantial share of deaths in the breed, and the predisposition is heritable, several genetic regions have been associated with it. Families with Bernese Mountain Dogs frequently know this disease by name before their dog is ever ill.

Flat-Coated Retrievers are the other strongly affected breed, and notably they develop the periarticular form disproportionately, the one with the better outlook.

Also overrepresented: Rottweilers, Golden Retrievers, Labrador Retrievers, Miniature Schnauzers (particularly the hemophagocytic form), and Pembroke Welsh Corgis.

Most dogs are middle-aged to older, commonly around seven or eight, though it occurs younger in the highly predisposed breeds.

Nothing you did caused this. In the affected breeds this is an inherited predisposition, and no dietary, environmental, or care-related cause has been established.

Signs to Look For

Signs depend entirely on where the disease is.

Around a joint:

• Lameness that persists and worsens
• Swelling around the knee or elbow
• Pain when the joint is manipulated
• Reluctance to exercise

In the lungs:

• Coughing
• Difficulty breathing or increased breathing effort
• Reduced stamina

In the spleen, liver, or bone marrow:

• Lethargy
• Reduced appetite and weight loss
• Pale gums
• Abdominal swelling
• Weakness or collapse

In the skin or underlying tissue:

• One or more firm lumps

In the central nervous system, less commonly:

• Seizures, incoordination, or behavior change

General signs across forms include fever, lethargy, and weight loss.

A persistent lameness in a Flat-Coated Retriever or Bernese Mountain Dog deserves prompt imaging rather than extended treatment as arthritis or a soft tissue injury. In these breeds specifically, joint-area lameness that is not resolving warrants X-rays.

How Histocytic Sarcoma is Diagnosed

Fine needle aspiration often provides useful information, as the cells have a distinctive appearance: Large, irregular, sometimes with multiple nuclei. In the hemophagocytic form, cells may be seen engulfing red blood cells.

Specialized staining is the step that confirms it. Histiocytic sarcoma resembles several other cancers on cytology alone, including lymphoma, amelanotic melanoma, and other sarcomas. Immunohistochemistry or immunocytochemistry using markers such as CD18 and Iba1 distinguishes them.

This matters practically, because the treatments differ substantially. If your dog has been diagnosed on cytology alone, it is reasonable to ask whether confirmatory testing has been done or should be.

Bloodwork is important beyond routine screening. The combination of anemia, low platelets, and low albumin points toward the hemophagocytic form, which changes both expectations and treatment approach.

Imaging: Chest X-rays, abdominal ultrasound, and joint X-rays where relevant, establishes whether the disease is localized or disseminated. This distinction is the most consequential thing staging tells you.

CT is used for surgical or radiation planning.

Bone marrow sampling may be performed where the marrow appears involved.

Treatment

Lomustine

Lomustine, often written CCNU, is the cornerstone drug for this cancer. It is an oral chemotherapy capsule given at home, typically every three weeks.

Reported response rates in dogs with measurable disease commonly fall around 30 to 50 percent, which is meaningful for a cancer this aggressive. Responses tend to be more durable in localized disease than disseminated disease, and the hemophagocytic form responds least well.

Lomustine affects the liver, so liver values are monitored throughout, and a liver-protective medication is often given alongside. It also suppresses blood cell production, particularly platelets, sometimes with a delayed effect appearing weeks later, which is why blood counts are checked regularly rather than only at the start.

Surgery

For a single mass around a joint, amputation of the affected limb combined with lomustine gives the best outcomes in this disease. Reported survival for this specific presentation frequently approaches or exceeds a year, and some dogs do considerably better.

If your dog has periarticular histiocytic sarcoma with no evidence of spread, this is the conversation to have, and it is worth having promptly.

Dogs adapt to limb loss far better than families expect, most stand within a day, walk within two, and return to normal activity within weeks. 

Splenectomy is performed where the spleen is the primary or dominant site, and is usually combined with chemotherapy.

Removal of localized masses elsewhere is worthwhile where achievable, again alongside chemotherapy.

Radiation

Radiation is used for localized disease where surgery is not possible or not chosen, and for palliating painful sites. It can provide useful local control, particularly for joint-area tumors in dogs who are not amputation candidates.

Other chemotherapy

Doxorubicin, epirubicin, and dacarbazine have been used, generally where lomustine is no longer working. Combination protocols are sometimes employed.

Response to second-line treatment tends to be shorter than the first, but it can provide additional meaningful time.

Supportive medical care

Transfusion may be needed for the severe anemia of the hemophagocytic form, and it can restore comfort quickly while other decisions are made.

Pain relief matters particularly for joint-area disease.

Anti-nausea medication and appetite support are worth requesting early rather than waiting.

Integrative and supportive care

Because lomustine affects the liver, be especially careful with anything else your dog ingests. Several herbal products are directly harmful to the liver, and a dog on lomustine has less reserve than usual. Milk thistle and SAMe are commonly used for liver support in this context and are generally regarded as low risk, but ask your oncologist before adding them.

Anything affecting clotting matters given the platelet suppression this drug causes. Fish oil and turmeric at higher doses fall into this category.

Tell your veterinary team about every product your dog receives.

Keeping your dog eating matters, as does gentle maintained routine and comfortable resting places. For dogs with joint disease or after amputation, traction underfoot and a supportive bed make a real difference.

No supplement, herb, or diet has been shown to treat histiocytic sarcoma in dogs. 

Comfort care alone

Given the outlook for disseminated and hemophagocytic disease, some families choose comfort-focused care from the outset, and that is a legitimate decision made by people who love their dogs.

It generally involves pain relief, steroids, anti-nausea medication, appetite support, and attention to breathing comfort. Steroids often produce a period of improved appetite and energy.

Discuss with your veterinarian what to expect and what the plan should be as things progress. Because this disease can move quickly, having that conversation early is more useful than waiting for a crisis.

What treatment is actually like for your dog

Lomustine is a capsule given at home, usually every three weeks. Most dogs experience no significant side effects. Those who do usually have mild nausea or reduced appetite for a day or two.

Handle the capsules with care — wear gloves, do not open or split them, keep them away from children, and wash your hands afterward. Pregnant and immunocompromised household members should not handle them.

Blood and liver monitoring is essential, not optional. Platelet suppression can appear weeks after a dose, and liver changes develop gradually. These are caught by monitoring rather than by symptoms, so keep those appointments even when your dog seems well.

Amputation recovery is faster than most families anticipate. Most dogs are standing within a day, walking within two, and moving confidently within two to four weeks. The first few days are genuinely difficult and many families describe a moment of doubt; that passes.

Splenectomy is major abdominal surgery with two to three days in hospital and about two weeks of restricted activity at home. Dogs live entirely normally without a spleen.

Radiation involves brief sessions under light anesthesia, with local skin irritation that settles over several weeks.

Understanding Prognosis

This is where honesty matters most, so these figures are stated plainly. They are medians across many dogs; half lived less, half lived longer.

• Localized periarticular disease treated with amputation and lomustine: frequently approaching or exceeding a year, with some dogs considerably longer
• Other localized disease treated with surgery and lomustine: commonly several months to around a year
• Disseminated disease: commonly one to four months
• Hemophagocytic form: commonly a few weeks to around two months
• Untreated disseminated disease: typically weeks

Factors associated with a better outcome include localized rather than disseminated disease, a periarticular site, response to lomustine, and normal albumin and platelet counts at diagnosis. Anemia, low platelets, and low albumin together indicate the hemophagocytic form and a shorter course.

This is an aggressive cancer and treatment controls it rather than eliminating it. What treatment offers most dogs is a period of feeling better than they would otherwise, and for the periarticular group specifically, that period can be substantial.

What It Costs

Costs vary by region and practice type. Ask for a written estimate.

• Aspiration with cytology: approximately $150 to $400
• Specialized staining to confirm the diagnosis: approximately $250 to $600
• Bloodwork: approximately $200 to $400
• Chest X-rays and abdominal ultrasound: approximately $700 to $1,200
• CT: approximately $1,500 to $3,000
• Amputation: approximately $2,000 to $5,000
• Splenectomy: approximately $3,000 to $6,000
• Lomustine: typically a few hundred dollars per dose, plus monitoring bloodwork
• Radiation: approximately $4,000 to $8,000
• Transfusion: approximately $500 to $1,500

Lomustine plus monitoring is the more affordable path and is the treatment most likely to help regardless of setting. A family who cannot pursue surgery or radiation is not left without an effective option.

Living With It Day-to-Day

Keep the monitoring appointments. Liver values and platelet counts change without visible signs, and dose adjustments depend on them.

Watch for bleeding: Bruising, small red spots on the gums or belly, black stool, or nosebleeds can indicate low platelets and should be reported.

Watch breathing and gum color. Increased breathing effort, coughing, or pale gums warrant prompt contact.

Report to your veterinary team: reduced appetite, lethargy, pale gums, coughing or breathing difficulty, new lumps, worsening lameness, bruising or bleeding, or any sudden change.

Rechecks typically include examination, bloodwork, and periodic imaging to assess response.

Questions Worth Asking Your Oncologist

• Was the diagnosis confirmed with specialized staining, or is it based on cytology alone?
• Is this localized or disseminated, and what was checked to determine that?
• Does my dog's bloodwork suggest the hemophagocytic form?
• If this is around a joint, is amputation with lomustine an option for us?
• What response rate do you expect from lomustine in my dog's situation?
• How often will liver values and platelets be checked?
• Are there clinical trials my dog might qualify for?
• What should I expect over the coming weeks, and what would signal a change?

Thinking About Quality of Life

Because this disease often moves quickly, quality-of-life thinking matters earlier here than in most cancers on this site. Waiting until a crisis to consider it usually means considering it under the worst possible conditions.

The measures that matter are appetite, energy, breathing comfort, pain, and engagement with the family. For dogs with the hemophagocytic form, weakness from anemia is often the dominant feature.

Track your dog daily or every few days rather than weekly, given how fast things can change: appetite, energy, comfort, breathing, and whether good days still outnumber bad. A short written note takes seconds and is far more reliable than memory when you are tired and frightened.

Ask your veterinary team early what the end of this disease typically looks like and what the plan should be. Families consistently describe having had that conversation in advance as one of the kindest things they did, because it meant the final decision was made calmly rather than in panic.

A Note for Bernese Mountain Dog Families

If you have a Bernese Mountain Dog, you may already have known this disease by name.

The predisposition is inherited, and research into the genetics is active and ongoing. Several institutions maintain research programs and biobanks focused specifically on histiocytic sarcoma in this breed, and participating, by contributing samples or clinical information, is something many families find worthwhile.

If your dog is diagnosed, ask your oncologist whether there is a study collecting cases. It does not help your dog directly, and it is entirely reasonable to decline. But it is one of the few avenues through which this disease may eventually become more treatable for the breed.

Common Questions

My young dog has a red button-shaped lump. Is that this cancer? Almost certainly not. That description matches cutaneous histiocytoma, a benign growth common in dogs under three that typically disappears on its own within one to three months. It is a completely different condition with an excellent outcome.

Is histiocytic sarcoma always fatal? It is an aggressive cancer and is controlled rather than eliminated. Outcomes vary considerably by form: localized disease around a joint, treated with amputation and lomustine, frequently gives close to a year or more, while the disseminated and hemophagocytic forms are measured in weeks to a few months.

Why does my Bernese Mountain Dog have this? The predisposition is inherited. Histiocytic sarcoma accounts for a substantial share of deaths in the breed, and multiple genetic regions have been associated with it. Nothing about your dog's care caused it.

What is lomustine, and does it work? It is an oral chemotherapy capsule given at home, and it is the most effective single drug for this cancer, with reported response rates commonly around 30 to 50 percent. It requires regular liver and blood count monitoring.

Should my dog have the leg amputated? If the tumor is around a joint and there is no evidence of spread, amputation combined with lomustine gives the best reported outcomes for this disease. Dogs adapt to limb loss far better than most families expect. It is worth discussing promptly.

How can they be sure it is this and not lymphoma? They may not be, on cytology alone. These cancers resemble each other under a microscope, and specialized staining using markers such as CD18 is what distinguishes them. If your dog was diagnosed without it, ask whether confirmatory testing is available.

My dog's bloodwork shows anemia and low platelets. What does that mean? Together with low albumin, that pattern suggests the hemophagocytic form, which arises in the spleen and bone marrow and destroys blood cells. It carries the shortest outlook of the forms and responds less well to chemotherapy. Transfusion can improve how your dog feels in the short term.

This page is for education and does not replace advice from your own veterinarian, who knows your dog. Pale gums with weakness or collapse requires immediate veterinary care.